Skip to main content
. 2022 Sep 17;23(18):10901. doi: 10.3390/ijms231810901

Figure 8.

Figure 8

Survival analysis of an 87-immune-gene signature in independent breast cancer cohorts. The identified 87-immune-gene signature predictive of pCR was subjected to RFS, OS, and DMFS in a cohort of basal (RFS: n = 442, OS: n = 296, DMFS: n = 283), HER2+ (RFS: n = 358, OS: n = 198, DMFS: n = 218), Luminal B (RFS: n = 566, OS: n = 200, DMFS: n = 183), and Luminal A (RFS: n = 631, OS: n = 222, DMFS: n = 259).